Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03685747 · ClinicalTrials.gov registry record · Phase 1
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
A Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT03685747 is a Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 4 participants.
The verdict
NCT03685747, a Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Vancomycin is the most commonly used empiric treatment for infectious peritonitis in patients on peritoneal dialysis. Current dosing and monitoring for safety and efficacy is empiric, especially for those on rapid-cycling modalities. The goal of this study is to understand the pharmacokinetics of vancomycin in patients on rapid-cycling peritoneal dialysis modalities in order to derive an optimal dosing regimen.
Interventions
- DRUG Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2020-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03685747
The ClinicalTrials.gov registry entry for NCT03685747 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vancomycin is the first listed.
NCT03685747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03685747 about?
NCT03685747 is a clinical study titled "Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis". Vancomycin is the most commonly used empiric treatment for infectious peritonitis in patients on peritoneal dialysis. Current dosing and monitoring for safety and efficacy is empiric, especially for those on rapid-cycling modalities. The goal of this study is to understand the pharmacokinetics of va...
What is the current status of trial NCT03685747?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2018-11-15. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT03685747?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT03685747?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.